HUM240705P330000
- 0.05
- -0.01-16.67%
Humana Newsroom
One Humana Insider Raised Stake By 34% In Previous Year
Mizhuo's Top Picks in Healthcare for July
Walmart Explores Sale Of Closed Health Clinics To Recoup Investments: Report
Walmart Inc. (NYSE:WMT) has reportedly entered discussions with prospective buyers to offload its recently closed medical clinics.
Walmart Exploring Possible Sale of Healthcare Centers: Report
Walmart (NYSE:WMT) has reportedly held talks with parties such as Humana (HUM) over a possible sale of its financially troubled healthcare centers business.
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were retreating late Tuesday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.4%. The iShares Biotechnology ETF (I
Market Chatter: Walmart in Talks to Sell Medical Clinics
Walmart (WMT) has discussed potential take over of its Walmart Health clinics that it has already started to close with potential buyers, including Humana (HUM), Fortune reported Tuesday, citing multiple sources familiar with the situation.
The Investment Guide for the 2024 USA Election is here! The best deployment time has come. Which US stocks are worth paying attention to?
Bank of America stated that the average monthly ROI of the S&P 500 index in the fourth year of a presidential cycle shows mediocre performance from January to May, a summer rebound from June to August, a fall before the election in September to October, and a post-election rebound in November and December.
"Interest rate cuts + Trump's return" two major expectations continue to ferment! Will this benefiting sector see the dawn?
Market participants believe that in recent three years, the biotechnology sector has been underperforming the broader market. Once the expectation of interest rate cuts is raised by the Fed, biotechnology companies, represented by innovative drugs, will have the ability to make up ground.
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
After the first televised debate for the US presidential election, the first wave of market reactions has arrived!
According to Goldman Sachs, the overall market activity on Friday experienced an explosive growth. Although US inflation cooled down in May, the long-term US Treasury yields reversed the early decline and soared at the close. Barclays recommends buying inflation-protected assets in preparation for Trump's victory.
US stocks closed lower on the last day of June with all three major indexes down. The AI-driven Nasdaq rose 18% in the first half of the year, while Nvidia soared 149%.
After hitting a new high, the S&P and Dow fell together, possibly due to Goldman Sachs and JPMorgan bearish on US stocks. Amazon, Google, and Microsoft fell from their recent highs, while most chip stocks rose. However, Nvidia rose 3% before falling 0.4% as the AI hype drove the Nasdaq up 18% and the S&P up 14.5% in the first half of the year.
'Trump' Stocks Are Rising: Banks, Managed Care, Steel -- Barrons.com
Andrew Bary Banks, managed care, steel makers, and other stocks that could be winners from a Trump presidency are rallying Friday while green energy stocks are lower. President Biden's weak showing
Shares of Managed Care and Health Insurance Stocks Are Trading Higher in Reaction to Thursday's Presidential Debate.
Shares of Managed Care and Health Insurance Stocks Are Trading Higher in Reaction to Thursday's Presidential Debate.
Medicare-related Stocks Rise After Poor Biden Debate Performance
A select handful of health insurance names popped on Friday following the first debate between President Joe Biden and former President Donald Trump.
Humana To Go Ex-Dividend On June 28th, 2024 With 0.885 USD Dividend Per Share
June 26th (Eastern Time) - $Humana(HUM.US)$ is trading ex-dividend on June 28th, 2024.Shareholders of record on June 28th, 2024 will receive 0.885 USD dividend per share on July 26th, 2024. The ex-div
Humana Stock: Is HUM Outperforming the Healthcare Sector?
Cigna, Humana Started at Overweight at Piper Sandler
Humana Has A 'Positive 6-Month Catalyst Path,' Says Bullish Analyst
Humana Inc (NYSE:HUM) recently inked an in-network deal with the University of Alabama at Birmingham's (UAB) Health System to provide Medicare Advantage members in the state greater access to care.The
Humana Initiated at Overweight by Piper Sandler
Humana Initiated at Overweight by Piper Sandler
Express News | Humana Inc : Piper Sandler Initiates Coverage With Overweight Rating; Target Price $392